Shows
Healthcare is Hard: A Podcast for Insiders340B Unpacked for the Holidays: Policy, Controversy, and ImpactSitting at the intersection of healthcare policy, hospital finance, and patient access, the 340B drug discount program is a hot button issues in the pharmacy space. The program is critically important to providers that serve high volumes of low income and vulnerable patient populations, but it’s drawing increasing scrutiny.340B was established in 1992 as part of the Public Health Services Act to help providers stretch scarce resources, expand services, and improve access to care for those most in need. It does this by requiring pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at significant discounts to...
2025-12-1835 min
Inside 340B ReportEpisode 30: Hospital 340B Rebate Pilot Lawsuit, HRSA Webinar Issues, Key CMS Policy UpdatesIn this episode, 340B Report Publisher and CEO Ted Slafsky joins Associate Editors and Senior Writers Shannon Young and Will Newton breaking down the latest in 340B news, including a new hospital lawsuit aiming to block the Health Resources and Services Administration's (HRSA) 340B rebate pilot, HRSA's recent webinar about that program, key regulatory updates on Medicare negotiated drug prices and a finalized hospital outpatient rule with significant implications for 340B hospitals and other stakeholders. Key Topics Covered: Hospitals Continue to Oppose Rebate Pilot Will breaks down a hospital group's new lawsuit urging...
2025-12-0521 minInside 340B ReportEpisode 28: Drugmaker Rebate Pilot Plans Unveiled, Mixed Decisions on Contract Pharmacy Laws, VA's 340B Election WinIn this episode, 340B Report Publisher and CEO Ted Slafsky and Associate Editors and Senior Writers Shannon Young and Will Newton break down the latest in 340B news, including the Health Resources and Services Administration's (HRSA) recent approval of drugmaker 340B rebate pilot plans—and the reactions they sparked; major court actions affecting Oklahoma and Colorado's 340B contract pharmacy access laws; and what Abigail Spanberger's (D) Virginia gubernatorial win could mean for 340B policy in that state. Key Topics Covered: Rebate Pilot Model Plans Approved, Unveiled Will provides an in-depth look at the ma...
2025-11-0730 minInside 340B ReportEpisode 27: HELP 340B Hearing Surprises, Grantees Conference Takeaways & Rebate Pilot Webinar RecapIn this episode, 340B Report Publisher and CEO Ted Slafsky and Associate Editors and Senior Writers Shannon Young and Will Newton break down the latest in 340B news, including the Senate Health, Education, Labor and Pensions (HELP) Committee's recent hearing on 340B, key takeaways from the 340B Grantees Fall Conference in Atlanta and 340B Report's recent webinar on the Health Resources and Services Administration's (HRSA) 340B rebate pilot and where we may be headed next on that controversial proposal. Key Topics Covered: Senate HELP Committee Mixes 340B Criticisms and Support Shannon and Will...
2025-10-2425 minInside 340B ReportEpisode 26: Govt. Shutdown's Impact on 340B, Rebate Pilot Concerns Grow, Pfizer Draws HeadlinesIn this episode, 340B Report Publisher and CEO Ted Slafsky and Associate Editors and Senior Writers Shannon Young and Will Newton break down the latest in 340B news, including the ongoing federal government shutdown's impact on 340B operations, the latest in the 340B rebate debate and a large drugmaker's move to tighten 340B restrictions on certain hospitals that it believes are not complying with the company's current contract pharmacy policy. Key Topics Covered: Federal Government Shutdown Could Affect 340B Program Operations Shannon explains how the federal government shutdown has led to furloughs at...
2025-10-1024 minInside 340B ReportEpisode 25: Bausch Health Bows Out of 340B, Federal Courts Side with States, Michigan Bill Faces AttacksIn this episode, 340B Report Publisher and CEO Ted Slafsky and Associate Editors and Senior Writers Shannon Young and Will Newton break down the latest in 340B news, including one drugmaker's removal of medications from the 340B and Medicaid Drug Rebate programs, recent developments in key 340B drug industry lawsuits and dark money groups' efforts to block Michigan's 340B contract pharmacy and reporting bill. Key Topics Covered: Bausch Health Pulls Drugs From 340B, Medicaid Rebate Programs Shannon discusses Bausch Health's recent decision to remove drugs from the 340B and Medicaid rebate programs effective...
2025-09-2626 minInside 340B ReportEpisode 24: 340B Rebate Pilot Proposal Comments, 340B ACCESS Act Resurfaces, New CBO ReportIn this episode, 340B Report Publisher and CEO Ted Slafsky and Associate Editors and Senior Writers Shannon Young and Will Newton break down the latest in 340B news, including the 1,000-plus public comments on the Health Resources and Services Administration's (HRSA) 340B rebate pilot proposal, the 340B ACCESS Act's reintroduction in Congress and a new Congressional Budget Office (CBO) report on 340B program growth, which has drawn criticism from provider advocates. Shannon and Will also provide updates on oral arguments in key federal cases that recently went before appeals court judges. Key Topics Covered: More...
2025-09-1230 minInside 340B ReportEpisode 23: 340B Rebate Update, Hospital Reclassification Trend and a Tribute to the Late Sue VeerIn this episode, Ted Slafsky, publisher and CEO of 340B Report, and Will Newton, associate editor and senior writer at 340B Report, break down the latest in 340B news, including concerns over the Health Resources and Services Administration's (HRSA) controversial 340B rebate pilot program and a new hospital Medicare reclassification trend that is alarming some rural health advocates. Next, they're joined by Colleen Meiman, a senior policy advisor to state primary care associations, to discuss the incredible life and legacy of Sue Veer, a nationally recognized 340B advocate and educator who passed away last week. Key Topics...
2025-08-2935 minInside 340B ReportEpisode 22: Rebate Update, Antitrust Case's 340B Implications & Closer Look at ASAP 340B AllianceIn this episode, 340B Report Publisher and CEO Ted Slafsky and Associate Editors and Senior Writers Shannon Young and Will Newton break down the latest in 340B news, including updates to the comment deadline on the Health Resources and Services Administration's (HRSA) 340B rebate guidance—and why 340B stakeholders say the agency's timeline is not long enough. They also reflect on the implications of a major ruling in an antitrust lawsuit that two health centers filed against drug manufacturers, which were among the first companies to impose 340B contract pharmacy restrictions. The team also discusses new 340B enrollment requirements fo...
2025-08-1832 minInside 340B ReportEpisode 20: Reconciliation Bill's 340B Impact, CMS' Big 340B Proposals and Rebate UpdateEpisode 20: Reconciliation Bill's 340B Impact, CMS' Big 340B Proposals and Rebate Update In this episode, 340B Report Publisher & CEO Ted Slafsky and 340B Report Associate Editor and Senior Writers Shannon Young and Will Newton break down the latest 340B news, including key developments in Washington D.C., a federal 340B rebate court case and the ongoing lobbying effort of the White House's Office of Management and Budget over a potential rebate model. Ted closes the episode with a touching tribute to his late mentor David Gergen. Key Topics Covered: Reconciliation Bill Becomes Law...
2025-07-1833 min
340B UnscriptedEp 71 | 2025 Midyear 340B Review – Conversation with Ted SlafskyIn this episode, Greg and Rob welcome back Ted Slafsky to recap what the first six months of 2025 have brought to the 340B landscape. They’ll talk about where we are at with 340B rebate model action, discuss how federal agency reorganization efforts could impact 340B regulatory oversight, recap state legislative wins for 340B providers and debate how Congress may address the call for 340B Program reform later in the year.
Come catch us at Booth #413 at the 2025 340B Coalition Summer Conference!
Listeners are welcome to use code “SpendMend25” to receive a 25% discount for new subscr...
2025-06-301h 00Inside 340B ReportEpisode 18: Impending Rebate Guidance, Possible 340B Move from HRSA to CMS & Oklahoma's Veto OverrideEpisode 18: Impending Rebate Guidance, Possible 340B Move from HRSA to CMS & Oklahoma's Veto Override In this episode, 340B Report Publisher and CEO Ted Slafsky, Associate Editors and Senior Writers Shannon Young and Will Newton and National Correspondent Bella Czajkowski break down the latest in 340B news, including the U.S. Department of Health and Human Services' (HHS) submission of 340B rebate guidance for regulatory review, a proposal to shift 340B oversight to the Centers for Medicare & Medicaid Services (CMS), U.S. Sen. Bill Cassidy's (R-La.) latest comments on 340B and Oklahoma's 340B contract pharmacy legislation veto override.
2025-06-0632 minInside 340B ReportEpisode 17: Court Weighs in on 340B Rebates, RFK Jr. Talks 340B, State UpdatesIn this episode, 340B Report Publisher and CEO Ted Slafsky and Associate Editor and Senior Writers Shannon Young and Will Newton break down the latest in 340B news, including a major federal court ruling on drugmaker 340B rebate models, Health and Human Services (HHS) Secretary Robert F Kennedy Jr.'s first public comments on the 340B program and the Oklahoma governor's decision to veto a widely supported contract pharmacy access bill. Key Topics Covered: Court Upholds HHS' Right to Pre-Approve 340B Rebates Will recaps the latest developments in a key 340B rebate lawsuit...
2025-05-2732 minInside 340B ReportEpisode 16: 340B Rebate and Antitrust Lawsuit Updates, More States Pass Contract Pharmacy Laws, Federal Drug Pricing Talks Heat Up In this episode, 340B Report Publisher and CEO Ted Slafsky, Associate Editor and Senior Writers Shannon Young and Will Newton and National Correspondent Bella Czajkowski break down the latest in 340B news, including developments in two major 340B lawsuits, new state contract pharmacy access laws with unique twists and developments on health funding negotiations and drug pricing policy talks in Washington, D.C. Key Topics Covered: Courts Hear Arguments in 340B Rebate, Antitrust Lawsuits Will recaps the latest developments in a key 340B rebate lawsuit, including recent oral arguments in which the drug industry argued...
2025-05-1230 min
340Banter PodcastHot Off the Press: 340B in the News with Ted SlafskyJoin co-hosts Chelsea Violette and Logan Yoho for a media-savvy deep dive with Ted Slafsky, founder and publisher of 340B Report, as they break down the latest headlines shaping the 340B world. From legislative developments to court rulings and industry shake-ups, Ted brings his insider perspective and journalistic expertise to help listeners make sense of the noise. Whether you're trying to stay current or understand how media narratives influence policy and practice, this episode delivers sharp analysis, timely updates, and behind-the-scenes insights you won’t find anywhere else.
2025-05-0825 minInside 340B ReportEpisode 15: Chairman Cassidy's 340B Inquiry, Trump's Executive Order, Pharma Tariffs and State BillsIn this episode, 340B Report Publisher & CEO Ted Slafsky joins Associate Editors and Senior Writers Shannon Young and Will Newton and National Correspondent Bella Czajkowski to break down the latest developments in the 340B space. The team discusses Senate HELP Committee Chair Bill Cassidy's (R-La.) high-profile report on the 340B program, an executive order sparking concerns among providers, reactions to potential pharmaceutical tariffs and important state 340B bills in Indiana and Tennessee. Key Topics Covered: Senate Report Calls for Congressional 340B Reform Sen. Cassidy unveiled the long-awaited findings of his two-year investigation into...
2025-04-2834 min
Pharmacy Innovators PodcastAdvancing 340B: Strategic Perspectives in a Changing LandscapeIn this episode of the Pharmacy Innovators Podcast, host Jim Jorgenson is joined by two powerhouse voices in the 340B space: Kristin Fox Smith, Visante’s own 340B expert, and Ted Slafsky, Publisher & CEO of the 340B Report.
Together, they dive into the latest political and regulatory shifts shaking the 340B landscape — from new Congressional leadership and pending legislation to the major reorganization of HHS and HRSA. The episode also explores Medicaid trends, judicial developments, contract pharmacy access, and the broader political forces shaping healthcare access for vulnerable populations.
Whether you’re a healthcare leader, policym...
2025-04-2433 minInside 340B ReportEpisode 13: State Bills Surge, Federal Updates and Major 340B Rebate DevelopmentsIn this episode, the Inside 340B Report team dives into a flurry of activity at the state and federal levels. Publisher and CEO Ted Slafsky and Associate Editor/Senior Writers Shannon Young and Will Newton break down the unprecedented wave of state-level 340B contract pharmacy access and provider reporting bills, explore key federal movements, including the latest on the bipartisan U.S. Senate working group behind the SUSTAIN 340B Act, and provide an update on 340B rebate litigation. Key Topics Covered: State Legislative Activity Heats Up The team discusses the recent surge in legislative...
2025-03-3130 minInside 340B ReportEpisode 12: Contract Pharmacy Bills Gain Momentum, Rebate Battles Rage OnIn this episode of Inside 340B Report, Ted Slafsky, Will Newton and Bella Czajkowski explore the latest developments in the 340B world at both the state and federal levels. They cover the progress of contract pharmacy access bills across the country—including a breaking news development—plus dark money efforts to oppose the legislation. They also break down key updates in drugmaker rebate lawsuits and provide an update on federal budget talks including major cuts expected for the Medicaid program and where we may be headed on the 340B program. Key Topics Covered: Contract Pharmacy Bill...
2025-03-1422 minInside 340B ReportEpisode 11: More States Join 340B Bill Surge, Congress Eyes Spending Cuts & 340B Coalition GathersIn this episode of Inside 340B Report, Ted Slafsky, Shannon Young, Will Newton and Bella Czajkowski discuss what may be a record-breaking year for state contract pharmacy access legislation with more than 20 states having already introduced such bills in 2025. On the federal front, the U.S. House's budget blueprint targeting $880 billion in health spending cuts over the next decade has raised alarm bells among providers over potential significant Medicaid reductions. Finally, Ted and Shannon share takeaways from last week's 340B Coalition Winter Conference in San Diego, where these topics and others were center stage. Key Topics Covered:
2025-03-0331 minInside 340B ReportEpisode 10: State-Level 340B Bills Gain Momentum, Dark Money Ads Intensify and D.C. DevelopmentsEpisode 10: State-Level 340B Bills Gain Momentum, Dark Money Ads Intensify and D.C. Developments In this episode of Inside 340B Report, Ted, Shannon, Will and Bella break down the latest developments shaping the 340B landscape. The team discusses the latest state contract pharmacy bill developments and a dark-money group's lobbying against them. They also touch on new GOP congressional budget proposals, new leadership at HHS and HRSA and key U.S. Senators' remarks on 340B's future. Key Topics Covered: State Contract Pharmacy Access and Provider Reporting Bills With the 2025 legislative sessions underway...
2025-02-1729 minInside 340B ReportEpisode 8: The New Congress, State 340B Legislation & New Program ScrutinyIn this new episode, Ted Slafsky catches up with Will Newton and Bella Czajkowski to analyze the latest 340B developments at both the federal and state levels, plus new scrutiny over the program and some of its stakeholders. With the 119th Congress underway, Ted explains what House and Senate committees and lawmakers 340B stakeholders should keep an eye on with narrow Republican control in both chambers. They also discuss the surge in new state-level 340B legislation, detail mixed reactions to a recent New York Times investigation on the 340B prime vendor Apexus, and recap a high-profile lawsuit and HRSA...
2025-01-2023 minInside 340B ReportEpisode 7: 340B Developments – Capitol Hill Chaos, Legal Battles and 2024's Top StoriesIn this final episode of the year, Ted Slafsky, Will Newton and Shannon Young unpack the most significant developments in the 340B program in both recent weeks and 2024. From the escalating legal battles over proposed 340B rebate models and pivotal state legislation to key court decisions and congressional activity, the team provides in-depth analysis of the year's top stories. They also share insights into what these shifts could mean for stakeholders and preview the issues expected to dominate the 340B landscape in 2025. Key Topics Covered: The Rebate Model Debate Will provides an update on t...
2024-12-2332 minInside 340B ReportEpisode 6: New Rebate Models, Contract Pharmacy Restrictions and the Republican TrifectaJoin Ted Slafsky, Shannon Young, Will Newton and Bella Czajkowski for another episode of Inside 340B Report. This week, the team unpacks the latest developments shaping the 340B landscape, from the announcement by drug manufacturers of new rebate models they hope to implement to expanding contract pharmacy restrictions. They also discuss how the incoming Republican-controlled Congress and White House could impact the 340B program. Key Topics Covered 340B Rebate Models and Legal Battles Will dives into the uptick in 340B rebate proposals from Johnson & Johnson, Eli Lilly, Bristol-Myers Squibb and Sanofi. Learn how these...
2024-12-0931 minInside 340B ReportEpisode 5: Post-Election Shifts and 340B Policy – Trump's New Administration and J&J's Legal PushTed Slafsky joins Shannon Young, Will Newton and Bella Czajkowski to analyze the 2024 election's potential impact on the 340B landscape, including how President-elect Donald Trump's return to the White House and the new GOP-controlled Congress could approach the drug pricing program.The team also discusses Johnson & Johnson's (J&J) recent lawsuit against the Health Resources and Services Administration (HRSA), marking a pivotal moment in the ongoing 340B rebate model debate. Key Topics Covered Election Results and 340B Policy Implications The team unpacks the election results, including Trump's decisive win and the new GOP leadership...
2024-11-1829 minInside 340B ReportEpisode 4: Forecasting Election Impact on 340B, Plus Continued Battles Over Contract PharmaciesWill Newton hosted this week's episode, leading a discussion with Shannon Young and Bella Czajkowski. Ted Slafsky was away for this edition, but we look forward to welcoming him back next time. In this new episode, the editorial team explores emerging trends in drugmaker contract pharmacy restrictions, legal developments around 340B eligibility calculations and manufacturer audits of covered entities, and how the upcoming congressional and presidential elections could shift the program's future. Key Topics Covered Emerging Trends in Contract Pharmacy Restrictions Bella overviews recent drugmaker moves to restrict contract pharmacy access beyond hospitals, sharing a...
2024-11-0422 minInside 340B ReportEpisode 2: HRSA Responds to J&J's Rebate Proposal; Capitol Hill Inquiries; State-Level BattlesIn episode 2, host Ted Slafsky, along with Will Newton and Bella Czajkowski, recap major news impacting the 340B program, including the future of manufacturer efforts to convert 340B to a rebate, Sen. Bill Cassidy's latest inquiry into two drugmakers, pushback from bipartisan House members to the rebate proposal federal 340B legislation and key state developments. Key Topics Covered Johnson & Johnson recently dropped its 340B rebate proposal amid strong enforcement threats from the federal government, but manufacturer efforts to convert the 340B program to a rebate model are likely to continue. The crew discusses the implications o...
2024-10-0731 minInside 340B ReportIntroducing the Inside 340B Report Editorial TeamEpisode 1: Introducing the Inside 340B Report Editorial Team Welcome to the very first episode of the Inside 340B Report podcast! In this debut episode, host Ted Slafsky, publisher and CEO of 340B Report, introduces listeners to the dynamic editorial team behind the show, Shannon Young, Will Newton, and Bella Czajkowski, as they share their backgrounds, experiences, and what drives their passion for the 340B Drug Discount Program. Meet the Team Ted Slafsky kicks off the episode by sharing his extensive background in journalism and advocacy. From his early days at U.S. News and World Report to...
2024-09-2320 minPharmacy Innovators Podcast340B Policy and Real-life ChallengesThe 340B landscape is constantly evolving, presenting both challenges and opportunities for healthcare providers. Visante is committed to helping organizations navigate the complexities that come with a 340B program.
To stay informed, listen to our latest podcast on all things 340B. Our guests, Ted Slafsky, Publisher and CEO of 340B Report, and Kristin Fox-Smith, Senior Vice President at Visante, discuss critical topics such as:
The evolving landscape of 340B advocacy
The importance of data sharing and transparency
The impact of telehealth on patient care
The role of audits in program integrity
The importance of an effective d...
2024-08-2135 min340B UnscriptedEp 48 | 2024 Midyear 340B Review - Conversation with Ted SlafskyIn this episode, Greg and Rob gear up for the 340B Summer Coalition conference, and are joined again by Ted Slafsky to discuss various 340B developments from the first half of 2024. They’ll discuss the ongoing contract pharmacy saga between entities and manufacturers, debate the future of proposed federal legislation addressing 340B Program reform, and recap pertinent court cases with both direct and indirect impact on 340B.
In the intro, the guys catch up on updated contract pharmacy restrictions and recent audit experiences.
Come find us at Booth #717 at the 2024 340B Coalition Summer Conference!
...
2024-07-071h 14
The Community Health Center Podcast340B History & Legislative Updates with the 340B ReportSend us a textIn this episode of The CHC Podcast hosts Chase Marable interviewed Ted Slafsky with 340B Report.We went go over critical trends impacting FQHCs including:- 340B Landmark Court Cases- 340B Federal & State Legislative Update
2024-04-2629 min340B UnscriptedEp 19 | 340B D.C. Update – Conversation with Ted SlafskyIn this episode, Rob and Greg are joined by guest Ted Slafsky, of 340B Report and Wexford Solutions (13:20). Ted shares his thoughts on the ongoing contract pharmacy impasse, updates on legislative developments coming out of D.C., and highlights some of the emerging advocacy groups as the debate over 340B Program reform heats up.
But first, Greg and Rob discuss upcoming recertification for grantee-covered entities and debate what the end of the COVID-19 Public Health Emergency means for 340B covered entities.
2023-05-081h 09